Vol 91, No 4 (2020)
Research paper
Published online: 2020-04-29

open access

Page views 1553
Article views/downloads 1190
Get Citation

Connect on Social Media

Connect on Social Media

The role of biological markers in predicting infertility associated with non-obstructive endometriosis

Nicolae Gica12, Anca Maria Panaitescu12, George Iancu12, Radu Botezatu12, Gheorghe Peltecu12, Corina Gica2
Pubmed: 32374018
Ginekol Pol 2020;91(4):189-192.


Objectives: Our study evaluates if the use of biological markers can predict the infertility in women with non-obstructive
Material and methods: Two prospective, non-randomised studies were conducted to identify if CA-125, IL-6 and IL-8 can be
used as predictive markers for infertility in women with non-obstructive endometriosis. Peripheral levels of CA-125, IL-6 and
IL-8 were measured before laparoscopy in all patients.
Results: We found a total number of 152 patients with non-obstructive endometriosis, we divided them in two groups: fertile
and infertile women. There was a statistically significant difference of the mean of CA-125 values between the two groups
(p = 0.00). The patients with infertility had a significantly higher IL-6 serum values than the fertile patients (p = 0.00). Regarding
the IL-8 serum values, there was no statistically significant difference between the two groups fertile vs infertile, (p = 0.06).
Conclusions: The elevated serum levels of CA-125 and IL-6 was associated with an increased probability of being diagnosed
with infertility. The IL-8 had no value in predicting infertility associated with non-obstructive endometriosis.

Article available in PDF format

View PDF Download PDF file


  1. Giudice L, Kao L. Endometriosis. The Lancet. 2004; 364(9447): 1789–1799.
  2. Fassbender A. Biomarkers of endometriosis. Fertility and Sterility. 2013; 99: 1135–1144.
  3. Eskenazi B, Warner M. Epidemiology of endometriosis. Obstetrics and Gynecology Clinics of North America. 1997; 24(2): 235–258.
  4. Fassbender A, Burney RO, O DF, et al. Update on Biomarkers for the Detection of Endometriosis. Biomed Res Int. 2015; 2015: 130854.
  5. Counseller V. Endometriosis. American Journal of Obstetrics and Gynecology. 1938; 36(5): 877–888.
  6. de Ziegler D, Pirtea P, Carbonnel M, et al. Implantation markers and endometriosis. Reprod Biomed Online. 2005; 11(4): 464–468.
  7. Carmona F, Chapron C, Martínez-Zamora MÁ, et al. Ovarian endometrioma but not deep infiltrating endometriosis is associated with increased serum levels of interleukin-8 and interleukin-6. J Reprod Immunol. 2012; 95(1-2): 80–95.
  8. Carp HJA, Selmi C, Shoenfeld Y. The autoimmune bases of infertility and pregnancy loss. J Autoimmun. 2012; 38(2-3): 266–274.
  9. May KE, Conduit-Hulbert SA, Villar J, et al. Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update. 2010; 16(6): 1–24.
  10. Gupta S, Agarwal A, Sekhon L, et al. Serum and peritoneal abnormalities in endometriosis: potential use as diagnostic markers. Minerva Ginecol. 2006; 58(6): 527–551.
  11. Othman EED, Hornung D, Salem HT, et al. Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. Eur J Obstet Gynecol Reprod Biol. 2008; 137(2): 240–246.
  12. Bedaiwy MA, Falcone T, Sharma RK, et al. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod. 2002; 17(2): 426–431.
  13. Ohata Y, Harada T, Miyakoda H, et al. Serum interleukin-8 levels are elevated in patients with ovarian endometrioma. Fertil Steril. 2008; 90(4): 994–999.
  14. Salmeri FM, Laganà AS, Sofo V, et al. Behaviour of cytokine levels in serum and peritoneal fluid of women with endometriosis. Gynecol Obstet Invest. 2002; 54(2): 82–87.